Recent News
IL-2
Cleveland Makes A Strong Case for Merck
Pictured above: Longtime Merck CEO Ken Frazier, JD, plans to step down 30 June 2021. Cleveland’s contentions have nothing to do with Frazier’s resignation and …
2Q Begins: Table Talk
Photo: Walt Disney’s April, May and June, nieces of Daisy Duck We enter a second leg of the year, the passage in which all months …
$azrx
Sapirstein’s Dirt of Luck
Prologomena to Any Future Steatorrhea Therapeutic Progress: An Open Letter to AzurRx CEO James Sapirstein By KSS, MD, PhD, Editor in Chief In military parlance, …
upcoming webcasts
What’s on BioPub-TV in April?
by KSS, MD, PhD, Editor-in-Chief Algernon CEO debriefs BioPub tomorrow morning (1 April, at 11 am EST) about the new data with ifenprodil and Covid …
AIRA
I Can See Clearly Now: Aira at BioPub
Pictured Above: Aira’s Emily Hill, Director of Customer Experience Aira Tech, Bursting with New Fans, Clients and Contracts, Returns to BioPub on 30 April 2021 …
$AGNPF
Have We Forgotten to Invest in Covid Therapeutics?
The Covid-19 Issue Too Many are Ready to Overlook, and the Investing Opportunity it Creates Have We Forgotten about Good Covid 19 Therapeutics? Three Gems …
capital raise
BioPub Private Investing Opportunities
by KSS, MD, PhD and Jonathan Coulborn, MBA We’ve needed a tracking and bookkeeping rubric regarding our private investing opportunities. Let’s let this column and …
2021
Long Ideas for 2021
Debuting BioPub’s Long Investing Ideas for 2021 by KSS, MD, PhD and Jonathan Coulborn, MBA Since it appears the BioPub chimney is erupting with plumes …
Bitcoin
This Just in from DLCC!
In a special meet-up this morning with DLCC CEO James Runnells, he disclosed plans to initiate a capital raise that the firm hopes to wind …
KSS Portfolio
Non-Newtonian Liquidity: KSS Portfolio March 2021
As a good BioPub essay should, this missive begins with a digression, a near-aleatory reverie to pay homage to how enigmatic life really is. Notice …
webcasts
Madness of March: Table Talk March 2021
Picture above: Alfred, Lord Tennyson For me and I hope for you, that we’ve make it to March each year is an annual reprieve, salvation …
Algernon
Professor David Nutt Drops by the Pub
Renowned British neuropsychopharmacologist Professor Dr. David Nutt (pictured above) pops by BioPub in the company of Algernon CEO Christopher Moreau for a lively, scintillating Algernon …
Join The BioPub
Community
Register now and gain access to our medical and science forums.
BIOPUB Webcasts
BioPub is the only biotech investing forum regularly providing readers top-tier unfettered live access to biotech executives…in the form of live webcasts once or twice weekly with new companies that have evoked editorial attention and established companies in the BioPub stable of investments. Our copyrighted, exclusive webcasts are recorded and archived on this website and sometimes on our youtube channel. Have a question for which the answer will influence your investment decision? Show up and ask.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
BIOPUB Webcasts
BioPub is the only biotech investing forum regularly providing readers top-tier unfettered live access to biotech executives…in the form of live webcasts once or twice weekly with new companies that have evoked editorial attention and established companies in the BioPub stable of investments. Our copyrighted, exclusive webcasts are recorded and archived on this website and sometimes on our youtube channel. Have a question for which the answer will influence your investment decision? Show up and ask.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
BioPub
a publication of Helixir Media, LLC
- KSS, MD, PhD, (New York): Founder
- Alan Harris (London): Founder
- KSS, MD, PhD, FACP: Editor-in-Chief and Publisher
- Jonathan Coulborn, MBA: Editor
- Glenn Newberry: Editor-at-Large
- Cleveland: Contributing Editor
- cw99, MD: Associate Editor
- Paul Harte: Associate Editor
- OneMdcn: Associate Editor
EDITORIAL BOARD
- Jonathan Coulborn: MBA, Chairman
- Tom Nall: Tampa, Florida
- cw99, MD: Austin, TX
- KSS, MD, PhD: ex officio
- Paul Harte: San Francisco, CA
- Melanie, MS: New York, NY
